463 related articles for article (PubMed ID: 31639221)
1. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
2. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
3. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
4. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
[TBL] [Abstract][Full Text] [Related]
5. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
6. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
[TBL] [Abstract][Full Text] [Related]
8. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
9. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
Malmgren JA; Mayer M; Atwood MK; Kaplan HG
Breast Cancer Res Treat; 2018 Jan; 167(2):579-590. PubMed ID: 29039120
[TBL] [Abstract][Full Text] [Related]
10. Ten-year survival in women with primary stage IV breast cancer.
Eng LG; Dawood S; Sopik V; Haaland B; Tan PS; Bhoo-Pathy N; Warner E; Iqbal J; Narod SA; Dent R
Breast Cancer Res Treat; 2016 Nov; 160(1):145-152. PubMed ID: 27628191
[TBL] [Abstract][Full Text] [Related]
11. Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
Liu N; Johnson KJ; Ma CX
Clin Breast Cancer; 2018 Oct; 18(5):e997-e1002. PubMed ID: 30007834
[TBL] [Abstract][Full Text] [Related]
12. Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.
Abdel-Rahman O
Clin Breast Cancer; 2019 Dec; 19(6):e717-e722. PubMed ID: 31519450
[TBL] [Abstract][Full Text] [Related]
13. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database.
Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR
Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
Roberts MC; Miller DP; Shak S; Petkov VI
Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
[TBL] [Abstract][Full Text] [Related]
15. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
Dignam JJ; Huang L; Ries L; Reichman M; Mariotto A; Feuer E
Cancer; 2009 Nov; 115(22):5272-83. PubMed ID: 19670456
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Feb; 168(1):269-275. PubMed ID: 29143220
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
18. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
19. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
20. Effects of marital status on breast cancer survival by age, race, and hormone receptor status: A population-based Study.
Zhai Z; Zhang F; Zheng Y; Zhou L; Tian T; Lin S; Deng Y; Xu P; Hao Q; Li N; Yang P; Li H; Dai Z
Cancer Med; 2019 Aug; 8(10):4906-4917. PubMed ID: 31267686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
